Global Antithrombin Market to 2023 - Rising Prevalence of Hereditary Antithrombin Deficiency

DUBLIN, Sept. 7, 2018 /PRNewswire/ --

The "Global Antithrombin Market - by Source, Dosage Form, Application, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)" report has been added to ResearchAndMarkets.com's offering.

The Global Antithrombin Market was worth 471.5 Million USD in 2017 and it is estimated to grow to 639.11 Million USD by 2023 with a CAGR of 5.2% between 2017 and 2023.

Antithrombin is a blood protein, which naturally functions as a mild blood thinner. Antithrombin helps to control too much clotting of blood. A person with low antithrombin levels has more tendencies to clot more easily and vice-versa.

Europe is expected to hold the largest share of Global Antithrombin Market due to significant adoption of antithrombin therapies followed by North America. Asia Pacific is expected to have the leading growth rate of 6.32%.

Drivers Vs. Constraints

Rising prevalence of hereditary antithrombin deficiency and rising antithrombin treatment among adults are the reasons which drive the Global Antithrombin Market growth.

Industry Structure and Updates

The key companies as Grifols, Shire Plc., and rEVO Biologics Inc. are engaged in research and development in order to accentuate their respective market shares.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Antithrombin Market Segmentation, Forecasts and Trends - by Source
5.1. Human
5.2. Goat Milk
5.3. Others

6. Global Antithrombin Market Segmentation, Forecasts and Trends - by Dosage Form
6.1. Liquid
6.2. Lyophilized

7. Global Antithrombin Market Segmentation, Forecasts and Trends - by Application
7.1. Diagnostics
7.2. Therapeutics
7.3. Research

8. Global Antithrombin Market Segmentation, Forecasts and Trends - by Region

9. Company Market Share Analysis

10. Company Profiles

• Grifols
• rEVO Biologics, Inc.
• Scripps Laboratories, Inc.
• Diapharma Group, Inc.
• Lee Bisolutions, Inc
• Dem ilac, Inc
• Octapharma AG
• Kedrion S.p.A.
• CSL Limited
• Shire plc

For more information about this report visit

https://www.researchandmarkets.com/research/x6gx8r/global?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content with multimedia:http://www.prnewswire.com/news-releases/global-antithrombin-market-to-2023---rising-prevalence-of-hereditary-antithrombin-deficiency-300708788.html

SOURCE Research and Markets